{Reference Type}: Journal Article
{Title}: Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms.
{Author}: Doskaliuk B;Zaiats L;Yatsyshyn R;Gerych P;Cherniuk N;Zimba O;
{Journal}: Rheumatol Int
{Volume}: 40
{Issue}: 10
{Year}: Oct 2020
{Factor}: 3.58
{DOI}: 10.1007/s00296-020-04658-6
{Abstract}: Systemic sclerosis (SSc) is a chronic progressive autoimmune disease characterized by immune inflammation, vasculopathy, and fibrosis. There are still numerous uncertainties in the understanding of disease initiation and progression. Pulmonary involvement in SSc, and particularly pulmonary fibrosis, is critical for all organ systems affections in this disease. This review is aimed to describe and analyze new findings in the pathophysiology of SSc-associated pulmonary involvement and to explore perspective diagnostic and therapeutic strategies. A myriad of cellular interactions is explored in the dynamics of progressive interstitial lung disease (ILD) and pulmonary hypertension (PH) in SSc. The role of exosomes, microvesicles, and apoptotic bodies is examined and the impact of micro and long non-coding RNAs, DNA methylation, and histone modification in SSc is discussed.